These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

376 related items for PubMed ID: 26001792

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The international, prospective Glanzmann Thrombasthenia Registry: treatment modalities and outcomes of non-surgical bleeding episodes in patients with Glanzmann thrombasthenia.
    Di Minno G, Zotz RB, d'Oiron R, Bindslev N, Di Minno MN, Poon MC, Glanzmann Thrombasthenia Registry Investigators.
    Haematologica; 2015 Aug; 100(8):1031-7. PubMed ID: 26001793
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The Use of Recombinant Activated Factor VII in Patients with Glanzmann's Thrombasthenia.
    Poon MC.
    Thromb Haemost; 2021 Mar; 121(3):332-340. PubMed ID: 33124022
    [Abstract] [Full Text] [Related]

  • 8. Glanzmann's thrombasthenia treatment: a prospective observational registry on the use of recombinant human activated factor VII and other hemostatic agents.
    Poon MC, Zotz R, Di Minno G, Abrams ZS, Knudsen JB, Laurian Y.
    Semin Hematol; 2006 Jan; 43(1 Suppl 1):S33-6. PubMed ID: 16427383
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Weekly low-dose recombinant factor VIIa prophylaxis in Glanzmann thrombasthenia.
    Andiç N, Oğuz N, Gündüz E, Kiraz Bulduk T, Üsküdar Teke H.
    Blood Coagul Fibrinolysis; 2021 Jul 01; 32(5):349-351. PubMed ID: 33878047
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Use of recombinant factor VIIa for bleeding in children with Glanzmann thrombasthenia.
    Cağlar K, Cetinkaya A, Aytaç S, Gümrük F, Gürgey A.
    Pediatr Hematol Oncol; 2003 Sep 01; 20(6):435-8. PubMed ID: 14631616
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Treatment of bleeding in patients with platelet disorders: is there a place for recombinant factor VIIa?
    Laurian Y.
    Pathophysiol Haemost Thromb; 2002 Sep 01; 32 Suppl 1():37-40. PubMed ID: 12214146
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Control of severe bleeding episode in case of Glanzmann's thrombasthenia refractory to platelet transfusion therapy by administering recombinant factor VIIa.
    Javed A, Ayyub M, Abrar S, Mansoor M, Khan B, Hussain T.
    J Ayub Med Coll Abbottabad; 2009 Sep 01; 21(2):171-3. PubMed ID: 20524499
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.